ERYTHROPOIETIC PROTOPORPHYRIA
Clinical trials for ERYTHROPOIETIC PROTOPORPHYRIA explained in plain language.
Never miss a new study
Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA trials appear
Sign up with your email to follow new studies for ERYTHROPOIETIC PROTOPORPHYRIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to let people with 'Sun Allergy' enjoy daylight
Disease control CompletedThis study tested whether an oral drug called bitopertin could help adults with erythropoietic protoporphyria (EPP), a condition causing severe pain from sunlight exposure. For about 4 months, 75 participants received either the real drug or a placebo pill to see if it reduced pa…
Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA
Phase: PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Common heartburn drug tested as potential lifeline for rare, painful sunlight disorder
Disease control CompletedThis study tested whether cimetidine, a common heartburn medication, could help people with rare genetic disorders (EPP and XLP) that cause severe, painful reactions to sunlight. In this Phase 2 trial, 26 participants took either cimetidine or a placebo for three months to see if…
Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA
Phase: PHASE2 • Sponsor: Amy K. Dickey, M.D. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Drug tested for rare sunlight allergy
Disease control CompletedThis study aimed to understand how the drug afamelanotide is processed by the body in people with erythropoietic protoporphyria (EPP), a rare condition causing severe pain from sunlight. It involved 28 adolescent and adult patients. Researchers measured the drug's levels in the b…
Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA
Phase: PHASE1, PHASE2 • Sponsor: Clinuvel Europe Limited • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC